Global Urinalysis Market is expected to foresee significant growth. APAC to lead the growth!
- Vikas Kumar
- January 14, 2023
- HEALTHCARE, NEWS
- Asia Urinalysis Market, Chronic Pain Market Growth, Europe Urinalysis Market, Middle east Urinalysis Market, Urinalysis, Urinalysis Market, Urinalysis Market analysis, Urinalysis Market forecast, Urinalysis Market growth, Urinalysis Market share, Urinalysis Market size, Urinalysis Market trend, US Urinalysis Market
- 0 Comments
Urinalysis or urine test utilizes urine samples to analyze the visual, chemical, and microscopic aspects of urine to assess patient health. These tests are routinely used by healthcare providers for the detection of specific health disorders and urinary tract infections. The market is growing at high rate which is attributed to the subsequent increase in the incidences of chronic diseases owing to lifestyle changes and rapidly increasing awareness regarding routine medical check-ups in developed countries. However, the high cost of urinalysis tests and inadequate healthcare policies in developing countries will restrain the growth of the market during the forecast period.
The Urinalysis Market is expected to grow at a steady rate of around 5.5% during the forecast period (2022-2028) owing to an increase in the geriatric population and the associated increase in age-related disorders. Due to the rapid growth in the elderly population, the incidences of age-related diseases, such as diabetes, liver, and kidney disorders have subsequently increased. According to the stats from World Health Organization, the number of people aged 60 years or above is expected to reach 1.4 billion by 2030. Apart from this, the higher risk of chronic kidney diseases and urinary tract infections with structural and functional changes in organs with aging will also propel the market’s growth. According to The National Center for Biotechnology Information, globally, around 6 million people are diagnosed with urinary tract infections every year.
Request for a sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31741
Based on product, the market is bifurcated into consumables and instruments. The consumables segment held the maximum share of the market. This is mainly due to the increasing demand and frequent purchases of reagents and dipsticks by laboratories and hospitals. Several companies including Siemens Healthcare GmBH., Abbott, and Roche offer high-quality consumables. For instance, Siemens Healthcare GmBH offers Multistix 10 SG Reagent Strips for diagnosis of UTI, diabetes, and kidney diseases.
Based on application, the market is categorized into disease screening and pregnancy & fertility testing. The disease screening segment is expected to have a significant share in the market due to the rise in the prevalence of urinary tract infections (UTI). According to the National Kidney Foundation, UTIs lead to approximately 10 million physician visits each year in the U.S. and are highly prevalent among women.
Based on the end-user, the urinalysis market is segmented into hospitals, clinical laboratories, home care, research & academics, and others. The clinical laboratories held the maximum share in the market which is due to the easy accessibility to patients and the availability of advanced products in these laboratories. In the U.S., more than 20,000 clinical laboratories perform clinical tests including urinalysis.
For a detailed analysis of the Global Urinalysis Market browse through– https://univdatos.com/report/urinalysis-market/
For a better understanding of the market adoption of the urinalysis industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period due to rising incidences of kidney diseases, urinary tract infections, technological advancements, and the rising geriatric population. In addition, the presence of several domestic urinalysis companies, such as VSI Electronics Pvt. Ltd and Medical Equipment India; increasing adoption of advanced urine analyses; and the presence of a large patient base with unmet clinical needs are some of the major factors boosting the regional market growth.
Some of the major players operating in the market include Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Abbott; Quidel Corporation; ACON Laboratories, Inc.; Sysmex Corporation; Cardinal Health Inc.; Thermo Fisher Scientific; and Danaher Corporation.
Global Urinalysis Market Segmentation
Market Insight, by Product
• Consumables
o Pregnancy & Fertility Kits
o Dipsticks
o Disposables
o Reagents
• Instruments
o Biochemical Urine Analyzers
Automated Biochemical Analyzers
Semi- Automated Biochemical Analyzers Market
Market Insight, by Application
- Disease Screening
- UTIs
- Diabetes
- Kidney Disease
- Hypertension
- Liver Disease
- Others
- Pregnancy & Fertility Testing
Market Insight, by End-User
- Hospitals
- Clinical Laboratories
- Home Care
- Research & Academics
- Others
Market Insight, by Region
- North America
- US
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Rest of the World
Top Company Profiles
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Abbott
- Siemens Healthineers
- ACON Laboratories, Inc.
- Sysmex Corporation
- Cardinal Health Inc.
- Thermo Fisher Scientific
- Danaher Corporation
Related Posts
